FDA accepts sNDA for higher regimen nusinersen for spinal muscular atrophy
The higher dose regimen of nusinersen comprises a more rapid loading regimen, two 50 mg doses 14 days apart, and higher maintenance regimen, 28 mg, every 4 months.
Food Insecurity and the Dangers of Infant Formula Dilution
IXCHIQ chikungunya vaccine meets phase 2 endpoint in children
Already approved in those aged 18 and older in the United States, Valneva has submitted label extension applications to the FDA for IXCHIQ use in adolescents aged 12 to 17 years.
Demystifying Infant Formula
AAP: These tips can keep kids comfortable amid cold & flu season
During the current cold and flu season, children have a higher risk of getting sick. The AAP has release tips and reminders for parents to help keep children comfortable and healthy.
New study identifies biomarkers that could prevent sudden infant death syndrome
UVA researchers identify key blood biomarkers linked to SIDS, paving the way for life-saving tests to detect and prevent this leading cause of death among infants.
